重磅！FDA批准首个间充质细胞疗法
0:15
重磅！FDA批准首个间充质细胞疗法
已浏览 478 次2024年12月19日
bilibili药时代
Mesoblast Gets US FDA Clearance to Proceed to Registrational Trial for Ryoncil in Duchenne Muscular Dystrophy
Mesoblast Gets US FDA Clearance to Proceed to Registrational Trial for Ryoncil in Duchenne Muscular Dystrophy
1 个月前
marketscreener.com
Mesoblast's Fiscal 2026 Net Revenue Projected to be Up to $120 Million, Jefferies Says
Mesoblast's Fiscal 2026 Net Revenue Projected to be Up to $120 Million, Jefferies Says
1 个月前
marketscreener.com
Could stem cell therapy help treat coronavirus?
3:04
Could stem cell therapy help treat coronavirus?
2020年4月25日
CBS News
Mesoblast Limited: FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil
Mesoblast Limited: FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil
2025年5月12日
finanznachrichten.de
An Off-the-Shelf Cell Therapy to Calm Cytokine Storms | The Bio Report | Mesoblast Limited
An Off-the-Shelf Cell Therapy to Calm Cytokine Storms | The Bio Report | Mesoblast Limited
已浏览 1.2万 次2 周前
linkedin.com
Mesoblast Limited: First Three Children to Commence Treatment With Ryoncil
Mesoblast Limited: First Three Children to Commence Treatment With Ryoncil
8 个月之前
finanznachrichten.de
Mesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean lab
2025年4月3日
hotcopper.com.au
Mesoblast Limited: Ryoncil FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings
2025年2月14日
finanznachrichten.de
Mesoblast annonce un chiffre d'affaires de 21,9 millions $ pour les ventes de Ryoncil : l'action grimpe de 8 %
7 个月之前
zonebourse.com
Advancements in Cardiovascular Care: Exploring Cell-based TherapiesThe Texas Heart Institute | Mesoblast Limited
已浏览 1.2万 次1 个月前
linkedin.com
Mesoblast Leads Global Regenerative Therapy Expansion
3 个月之前
marketscreener.com
Mesoblast prepares to launch FDA-approved therapy for Pediatric Steroid-Refractory aGVHD
2025年1月9日
proactiveinvestors.com.au
Hot Stocks: Mesoblast, Rio Tinto, Silex Systems - Sharecafe
4 个月之前
sharecafe.com.au
Mesoblast kicks off treatment for first 3 kids with graft-host disease. So why are shares down?
2025年3月31日
hotcopper.com.au
Mesoblast achèvera le traitement Ryoncil pour 63 patients au cours de l'exercice 2026, selon Jefferies
7 个月之前
zonebourse.com
Thursday's HotCopper Trends: Mesoblast bags FDA tick, Hot Chili extends mine life | March 27, 2025
2025年3月26日
hotcopper.com.au
US FDA approves Mesoblast's cell therapy for graft-versus-host disease
2024年12月18日
marketscreener.com
0:59
Friday's HotCopper Trends: Mesoblast dodges tariffs, Orthocell's FDA tick | April 4, 2025
2025年4月4日
MSNHotCopper.com
Mesoblast Limited: Mesoblast's RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
2024年12月19日
finanznachrichten.de
0:53
Thursday’s HotCopper trends: Mesoblast's FDA tick, Anson's green light | May 15, 2025
2025年5月15日
MSNHotCopper.com
Australia sẽ ra mắt thuốc điều trị biến chứng Covid-19 vào cuối năm nay
2020年8月27日
kenh14.vn
1:10
Tuesday’s HotCopper Trends: IT stocks tank, Mesoblast bags FDA tick & Hot Chili extend mine life | March 27, 2025
2025年3月27日
MSNHotCopper.com
Mesoblast kicks off Ryoncil sales in US but shareholders eager for revenue
2025年3月27日
hotcopper.com.au
HotCopper Highlights Week 20: Mesoblast FDA miss; Larvotto posts tungsten, Melbana & More
2025年5月15日
hotcopper.com.au
展开
静态缩略图占位符